TCRT News and Press, Alaunos Therapeutics Inc. From 12/18/23

2023-12-18 08:47:10 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Ebix (NASDAQ: EBIX ) stock is falling hard on Monday after the on-demand infrastructure software company filed for Chapter 11 bankruptcy protection . According to a press re...

2023-12-18 08:21:37 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips ICoreConnect (NASDAQ: ICCT ) stock is rising higher on Monday even without any clear news from the cloud-based software and technology company . There are no new press relea...

2023-12-18 07:57:12 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Alaunos Therapeutics (NASDAQ: TCRT ) stock is up on Monday despite a lack of news from the clinical-stage oncology-focused cell therapy company . There are no new press rele...

2023-12-18 07:35:41 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s time to start the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Monday! Moving stocks are an acquisition deal, delisting update, bankr...

2023-11-14 08:54:57 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Fisker (NYSE: FSR ) stock is taking a beating on Tuesday after the company posted its earnings results for the third quarter of 2023. One bit of news from that earnings report t...

2023-11-14 08:31:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Trivago (NASDAQ: TRVG ) stock is on the move Tuesday as the company’s American Depository Shares ( ADS ) prepare for a ratio change . The big news here is that TR...

2023-11-14 08:13:49 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Beauty Health (NASDAQ: SKIN ) stock is taking a beating on Tuesday after the aesthetic technologies and products company released its third-quarter earnings report . The bad...

2023-11-14 07:56:57 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Alaunos Therapeutics (NASDAQ: TCRT ) stock is heading higher on Tuesday following the release of the clinical-stage oncology-focused cell therapy company’s third-quarter ea...

TCR-T Library Phase 1/2 trial achieved an 87% disease control rate of eight evaluable patients with metastatic, refractory solid tumors; TCR-T cell therapy was well tolerated in all treated patients hunTR® discovered new HLA class I and class II restricted TCRs that recognize d...

INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...